<DOC>
	<DOCNO>NCT02086994</DOCNO>
	<brief_summary>We aim compare carbetocin misoprostol prevention postpartum hemorrhage patient severe preeclampsia . The primary outcome postpartum haemorrhage ( blood loss ≥ 500 ml ) Secondary outcome include use additional uterotonics , need blood transfusion , maternal adverse drug reaction , maternal complication maternal death</brief_summary>
	<brief_title>Prevention Postpartum Hemorrhage Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol</brief_title>
	<detailed_description>We conduct prospective non-randomized study Department Obstetrics Gynecology , Benha University Hospital , since March 2013 till June 2015 , approval study protocol Local Ethical Committee . A write informed consent obtain eligible woman induction early stage labour . Women singleton pregnancy 28 week ' gestation admit hospital severe preeclampsia candidate vaginal delivery eligible study . Preeclampsia label severe presence follow abnormality . 1 . Persistent cerebral visual disturbance cerebral edema . 2 . Persistent epigastric pain nausea vomiting , . 3 . Systolic ≥160 mmHg diastolic ≥110 mmHg 2 occasion least 6 h apart patient bed rest . 4 . Proteinuria ≥5 g 24-hour urine collection . Urine dipstick accurate purpose . 5 . Oliguria ( ˂500 mL 24 hour ) . 6 . Pulmonary edema . 7 . Thrombocytopenia . Our exclusion criterion HELLP syndrome , eclampsia , abruptio placenta , malpresentation , polyhydramnios , previous uterine scar , chorioamnionitis multiple pregnancy . All patient stable condition ( evidence maternal hemodynamic instability fetal distress ) management afterwards follow standard accept country establish guideline management hypertensive disorder pregnancy . For hypertensive crisis first drug use hydralazine ( 5 mg IV every 15 minute maximum total dose 20 mg ) , ineffective , Nifedipine ( Epilat ) : 10 20 mg orally / 30 min ( max 50 mg ) , Then 10-20 mg /4-6 h ( max 120 mg/day ) labetalol ( 20 mg IV every 10 minute maximum total dose 300 mg ) . No patient need additional treatment symptom develop antepartum complication require admission intensive care unit . All patient evaluate hourly receive magnesium sulphate prevent eclampsia pregnancy minimum 24 hour postpartum . The patient ( 60 ) divide two group , Group A ( 30 ) receive single dose carbetocin ( 100 μg 1 mL ampoule , Pabal ) Group B ( 30 ) receive misoprostol ( 600 μg , 3 table ) sublingually delivery anterior shoulder baby . The third stage labour manage usual clamp cut umbilical cord , wait sign placental separation deliver placenta control cord traction . Duration 3rd stage labour calculate . Patient keep labor room observation period 1 h complaint nausea , vomit , fever , headache , chill , diarrhoea shivering note . In case uterine atony ( determined physical examination continuous postpartum bleed ) uterus massage additional uterotonics give note ( oxytocin and/or prostaglandin , discretion attend physician ) . Any requirement manual removal placenta blood transfusion also record . The following laboratory assessment ( hemoglobin , hematocrit , platelet , renal liver function test ) perform every patient admission postpartum . Vital sign ( blood pressure , heart rate , respiratory rate ) urine output measure every hour least 24 hour delivery . Measurement blood loss A clean plastic line absorbent drape place woman 's buttock collect blood lose delivery baby drainage amniotic fluid . The drape change many time need . The woman stay drape ask wear pad next 60 minute . In case severe haemorrhage , follow usual guideline management postpartum haemorrhage , supplemental treatment register . All drape pad weigh electronic scale know dry weight linen subtract . As 1 ml blood weighs close 1 g , balance gram assume total blood loss ml . Haemoglobin concentration measure , 2 hour 24 hour delivery . The rate haemorrhage labour third phase determine observation estimation consider amount blood patient . The rate haemoglobin haematocrit measure hospitalization also 2 h , 24 h delivery record . At interval , patient evaluate term possible complication administer drug vomit , diarrhoea , shiver , pyrexia , headache ) . All patient Foley catheter situ 24 hour delivery amount urine monitor hourly . This study external funding source . No author potential relationship may pose conflict interest . Outcome measure Our primary outcome measure postpartum haemorrhage , define blood loss ≥ 500 ml . We analyse blood loss , change haemoglobin concentration admission discharge . While secondary outcome include use additional uterotonics , need blood transfusion , maternal adverse drug reaction ( headache , vomit , abdominal pain , pruritus , tacky bradycardia ) , sever maternal complication ( seizure need ICU admission ) maternal death .</detailed_description>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>Puerperal Disorders</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Women singleton pregnancy 28 week ' gestation admit hospital severe preeclampsia candidate vaginal delivery eligible study . Preeclampsia label severe presence follow abnormality : 1 . Persistent cerebral visual disturbance cerebral edema . 2 . Persistent epigastric pain nausea vomiting , . 3 . Systolic ≥160 mmHg diastolic ≥110 mmHg 2 occasion least 6 h apart patient bed rest . 4 . Proteinuria ≥5 g 24hour urine collection . Urine dipstick accurate purpose . 5 . Oliguria ( ˂500 mL 24 hour ) . 6 . Pulmonary edema . 7 . Thrombocytopenia . HELLP syndrome , eclampsia , abruptio placenta , malpresentation , polyhydramnios , previous uterine scar , chorioamnionitis multiple pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>carbetocin , misoprostol , pre-eclampsia , pph</keyword>
</DOC>